These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 1986740

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A method for generating toxic vapors of soman: toxicity of soman by inhalation in rats.
    Aas P, Sterri SH, Hjermstad HP, Fonnum F.
    Toxicol Appl Pharmacol; 1985 Sep 30; 80(3):437-45. PubMed ID: 4035697
    [Abstract] [Full Text] [Related]

  • 5. Esterase activities and soman toxicity in developing rat.
    Sterri SH, Berge G, Fonnum F.
    Acta Pharmacol Toxicol (Copenh); 1985 Aug 30; 57(2):136-40. PubMed ID: 4061089
    [Abstract] [Full Text] [Related]

  • 6. Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat.
    Jimmerson VR, Shih TM, Maxwell DM, Mailman RB.
    Toxicol Lett; 1989 Jul 30; 48(1):93-103. PubMed ID: 2749782
    [Abstract] [Full Text] [Related]

  • 7. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM, Brecht KM, Lenz DE, O'Neill BL.
    J Pharmacol Exp Ther; 1988 Sep 30; 246(3):986-91. PubMed ID: 3418520
    [Abstract] [Full Text] [Related]

  • 8. Effect of soman administration on beta-esterases in blood, liver microsomes and brain regions of rats.
    Purshottam T, Kaveeshwar U.
    Indian J Physiol Pharmacol; 1992 Jul 30; 36(3):197-200. PubMed ID: 1473852
    [Abstract] [Full Text] [Related]

  • 9. Carboxylesterase inhibition and potentiation of soman toxicity.
    Cohen SD.
    Arch Toxicol; 1981 Nov 30; 49(1):105-6. PubMed ID: 7053071
    [No Abstract] [Full Text] [Related]

  • 10. Iso-OMPA-induced potentiation of soman toxicity in rat correlates with the inhibition of plasma carboxylesterases.
    Grubic Z, Sket D, Brzin M.
    Arch Toxicol; 1988 Nov 30; 62(5):398-9. PubMed ID: 3242452
    [Abstract] [Full Text] [Related]

  • 11. The effects of blood flow and detoxification on in vivo cholinesterase inhibition by soman in rats.
    Maxwell DM, Lenz DE, Groff WA, Kaminskis A, Froehlich HL.
    Toxicol Appl Pharmacol; 1987 Mar 30; 88(1):66-76. PubMed ID: 3564032
    [Abstract] [Full Text] [Related]

  • 12. Role of carboxylesterase in protection against soman toxicity.
    Purshottam T, Srivastava R.
    Pharmacology; 1989 Mar 30; 38(5):319-26. PubMed ID: 2762374
    [Abstract] [Full Text] [Related]

  • 13. Sodium pentobarbital alteration of the toxicity and distribution of soman (pinacolyl methylphosphonofluoridate) in mice.
    Clement JG.
    Biochem Pharmacol; 1984 Feb 15; 33(4):683-5. PubMed ID: 6704186
    [No Abstract] [Full Text] [Related]

  • 14. Importance of aliesterase as a detoxification mechanism for soman (Pinacolyl methylphosphonofluoridate) in mice.
    Clement JG.
    Biochem Pharmacol; 1984 Dec 01; 33(23):3807-11. PubMed ID: 6508835
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Carboxylesterases, importance for detoxification of organophosphorus anticholinesterases and trichothecenes.
    Fonnum F, Sterri SH, Aas P, Johnsen H.
    Fundam Appl Toxicol; 1985 Dec 01; 5(6 Pt 2):S29-38. PubMed ID: 4092894
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Formation of soman (1,2,2-trimethylpropyl methylphosphonofluoridate) via fluoride-induced reactivation of soman-inhibited aliesterase in rat plasma.
    de Jong LP, van Dijk C.
    Biochem Pharmacol; 1984 Feb 15; 33(4):663-9. PubMed ID: 6704183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.